Evidence map›Paper›PMID 35893366›Full record

ArticleJournal of clinical medicine2022

Calibration and Validation of a PREMIUM-DT Item Bank to Measure the Experience of Drug Therapy for Patients with Severe Mental Illness.

Sara Fernandes, Laurent Boyer, Xavier Zendjidjian, Anderson Loundou, Jeremie Riedberger, Pierre-Michel Llorca, Pascal Auquier, Guillaume Fond, Collaborators Of The French Premium Group

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sara FernandesCEReSS-Health Service Research and Quality of Life Center (UR3279), Aix-Marseille University, 13005 Marseille, France.
Laurent BoyerCEReSS-Health Service Research and Quality of Life Center (UR3279), Aix-Marseille University, 13005 Marseille, France.ORCID 0000-0003-1229-6622
Xavier ZendjidjianCEReSS-Health Service Research and Quality of Life Center (UR3279), Aix-Marseille University, 13005 Marseille, France.
Anderson LoundouCEReSS-Health Service Research and Quality of Life Center (UR3279), Aix-Marseille University, 13005 Marseille, France.ORCID 0000-0003-4301-9476
Jeremie RiedbergerCEReSS-Health Service Research and Quality of Life Center (UR3279), Aix-Marseille University, 13005 Marseille, France.
Pierre-Michel LlorcaFondation FondaMental, 94000 Créteil, France.ORCID 0000-0001-7438-8990
Pascal AuquierCEReSS-Health Service Research and Quality of Life Center (UR3279), Aix-Marseille University, 13005 Marseille, France.
Guillaume FondCEReSS-Health Service Research and Quality of Life Center (UR3279), Aix-Marseille University, 13005 Marseille, France.
Collaborators Of The French Premium Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to (1) calibrate an item bank to measure patients’ experience of drug therapy for adult patients with SMIs and (2) develop computerized adaptive testing (CAT) to improve its use in routine practice. This is a cross-sectional, multicentric study involving 541 patients with schizophrenia, bipolar disorder, and major depressive disorder. Analyses based on classical test and item response theories were performed. After 7 highly inter-correlated items and 4 items with low factor loadings were removed, the remaining 26 items were sufficiently unidimensional (RMSEA = 0.069, CFI = 0.969, TLI = 0.963) and showed adequate fit to the generalized partial credit model. There was no differential item functioning by gender, age, care setting, or diagnosis from moderate- to large-magnitude. The mean score was 46.0 ± 16.9 and was significantly higher for patients reporting good medication adherence. The resulting PREMIUM-DT item bank has strong psychometric properties, and CAT facilitates widespread use in clinical settings (an average of 8 items administered, corresponding to a reliability of >0.90). Our results suggest that practical information and information about the side effects of psychotropic treatments and how to cope with them should be targeted as a priority to improve patients’ experience of drug therapy.

Indexed as

bipolar disordersdepressive disordershealth services researchmental healthpatient-reported experience measurespsychiatryschizophrenia

Identifiers

PMID35893366
PMCPMC9331305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.